Published • loading... • Updated
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation
The company expects gross profit to rise 801% and operating cash flow to turn positive in 2027 as it shifts toward higher-margin proprietary products.
Summary by Globe Newswire
7 Articles
7 Articles
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 -- Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation
Cosmos Health enters this guidance period following its strongest financial performance in Company history — full year 2025 revenue of $65.3 million, up 20% year-over-year, with gross profit increasing 83%, gross margin expanding 418 basis points, and cash rising more than tenfold to $3.5 million.
·Canada
Read Full Article
The Toronto Star+5 Reposted by 5 other sources
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation
Revenue increasing 207% at a 32% CAGR: From $65.3 million in 2025 to $200.6 million by 2029, driven by strong growth across all core segmentsGross profit growing 801% to $71.2M:
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left5Leaning Right1Center1Last UpdatedBias Distribution72% Left
Bias Distribution
- 72% of the sources lean Left
72% Left
L 72%
14%
14%
Factuality
To view factuality data please Upgrade to Premium
